Expression of peptidylarginine deiminase type 4 in ovarian tumors.
about
Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.Investigating the pathogenic role of PADI4 in oesophageal cancerChemical biology of protein arginine modifications in epigenetic regulationPotential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis.A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cellsFolded Conformation, Cyclic Pentamer, Nano-Structure and PAD4 Binding Mode of YW3-56.Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis.Role of peptidylarginine deiminase type 4 in gastric cancer.PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure.Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?Peptidylarginine deiminase IV promotes the development of chemoresistance through inducing autophagy in hepatocellular carcinoma.Fluorescence-based monitoring of PAD4 activity via a pro-fluorescence substrate analog.Induction of protein citrullination and auto-antibodies production in murine exposed to nickel nanomaterials.Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report.
P2860
Q30523071-EEF4663D-A560-4A4D-BCDD-66BA76FBE6C4Q35059255-CEDF0020-1377-451B-B094-D094E4E0AF9AQ35722457-EF1747A1-27CF-4A9A-81F1-B34C2839C27DQ36277576-AE13337F-F663-4896-98E1-42CF4D04E2FEQ36772066-67D97DAE-7B6D-44CC-A533-386BA2E0D946Q36937240-7F745990-DA6F-475C-9ED6-86C22C310DBCQ37209628-737FBE2F-8085-432D-8AF5-1C60C1E82498Q37402448-5EB361F1-6BB6-4F88-BE7E-D79860E612ECQ37406509-E2C12C98-0A98-477A-B5E4-D65E70EA9AE6Q37641748-BFBC59AE-084B-4375-B1A9-377EAAB95BFFQ38443364-FB850561-DEDD-405E-9191-53BD0B11F32AQ38747640-A6EB7ACB-A952-45CE-A873-CC6EA2D4917FQ38819858-B6BFAC6C-D27E-4586-9D09-392EFCB9EB3AQ38929364-13941E4F-1A9B-46C0-A308-FC626D11D226Q39294195-E978BB4D-1CF1-4191-96B1-0FD893867055Q39354673-753225AF-16A5-4602-AFD0-E54E671FE967Q40012998-9428B430-35AE-4A6A-9AE9-537ABEF0DAE3Q41893154-A0965BC5-2860-4685-90DD-83EFEFD35349Q48251344-A69CEBDE-A400-44A8-9E78-4DF32D440F1AQ53034884-34CA6FE2-0A32-408A-B0C9-690B53E3CFBF
P2860
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@ast
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@en
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@nl
type
label
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@ast
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@en
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@nl
prefLabel
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@ast
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@en
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@nl
P2093
P2860
P356
P1476
Expression of peptidylarginine deiminase type 4 in ovarian tumors.
@en
P2093
Guangying Yuan
Pengcheng Wang
Xiaotian Chang
P2860
P304
P356
10.7150/IJBS.6.454
P407
P577
2010-08-27T00:00:00Z